Our findings also support the hypothesis that this attenuated growth is mediated in part by impaired protein synthesis, as activation of the mammalian target of rapamycin (mTOR) pathway is markedly reduced as early as 4 weeks after the development of T1DM. This evidence concerns the gene MTOR and type 1 diabetes mellitus.